Compare Abeona Therapeutics Inc (ABEO) vs ADMA Biologics Inc (ADMA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs ADMA Biologics Inc — how do they compare? Abeona Therapeutics Inc trades at $7.42 (market cap $421.19M), while ADMA Biologics Inc trades at $9.91 (market cap $2.22B). The key difference: ADMA Biologics Inc is far larger — about 5.3× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | ADMA | |
|---|---|---|
Market Cap | $421.19M | $2.22B |
Sector | Health | Health |
52-Week High | $7.45 | $20.38 |
52-Week Low | $4.17 | $7.60 |
Enterprise Value | $276.10M | $2.29B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →
